McCoy v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJanuary 8, 2025
Docket20-1321V
StatusUnpublished

This text of McCoy v. Secretary of Health and Human Services (McCoy v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McCoy v. Secretary of Health and Human Services, (uscfc 2025).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1321V

************************* LATOYA MCCOY, * Chief Special Master Corcoran * * * Petitioner, * Filed: October 15, 2024 * v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * *************************

Mark Sadaka, Law Offices of Sadaka Associates, LLC, Englewood, NJ, for Petitioner.

Felicia Langel, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION DISMISSING CASE1

On October 5, 2020, Latoya McCoy filed a petition for compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”),2 ECF No. 1 (“Petition”). Petitioner alleges that she experienced left shoulder pain and/or adhesive capsulitis after receiving an influenza (“flu”) vaccine on October 8, 2017.

The matter was originally assigned to the Special Processing Unit (“SPU”), based on the assumption that Petitioner had alleged something akin to the Table claim of a shoulder injury

1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa. related to vaccine administration, or “SIRVA,” suggesting in turn that it was likely to settle. But intractable fact disputes resulted in the claim’s transfer to my docket.

Respondent has now moved to dismiss the claim, arguing that Petitioner cannot meet the SIRVA Table elements, and otherwise has not established a viable causation-in-fact claim. Motion to Dismiss, dated July 24, 2024 (ECF No. 49) (“Mot.”). Petitioner opposes the motion, maintaining that she has established a prime facie case for a SIRVA-like injury, even if the facts do not meet all of the Table elements. Opposition, dated August 29, 2024 (ECF No. 50) (“Opp.”).

Having reviewed the parties’ submissions, I hereby determine (as discussed below) that Petitioner has not offered sufficient evidence to meet either the Table SIRVA elements or to establish a viable causation-in-fact claim – mainly, although not exclusively, due to the fact that the record preponderates in favor of the conclusion that Petitioner’s injury predated vaccination. For this reason, Respondent’s Motion to Dismiss is granted.

I. Factual Background

Prior to receipt of the flu vaccine, Ms. McCoy had a history of intractable migraines. See generally Ex. 3. Petitioner also reported bilateral shoulder pain in 2015 and 2016. Id. On October 8, 2017, Petitioner visited a Walgreens pharmacy and received the flu vaccine intramuscularly in her left deltoid. Ex. 9 at 3.

There is no medical record evidence of any claimed immediate vaccine reaction. However, Petitioner filed four declarations to support her claim that she experienced pain and weakness immediately following the vaccine. In the first, Petitioner states that she noticed pain in her left shoulder and arm one week after she received the flu vaccine. See Declaration of Latoya McCoy, dated December 14, 2020 (ECF No. 9). In her second declaration, Petitioner explains that she delayed seeking treatment for her arm because of her severe migraines, and the need to prioritize their treatment. See Declaration of Latoya McCoy, dated October 28, 2022 (ECF No. 36). Petitioner’s daughter also filed a declaration claiming that Petitioner complained of arm pain “shortly after she received the [October 2017] flu vaccine,” and required assistance with holiday preparations due to ongoing pain. See Declaration of Jondashia Mingo, dated September 14, 2022, filed as Ex. 13 (ECF No. 36-1). And a declaration from Petitioner’s work colleague states that Petitioner required assistance at work and missed workdays due to arm pain from “the flu vaccine in October 2017.” See Declaration of Ashland Edwards, dated September 14, 2022, filed as Ex. 14 (ECF No. 36-2).

Despite the allegations set forth in these declarations, Petitioner’s first visit to any physician following receipt of the vaccine occurred on November 30, 2017 – six weeks post-

2 vaccination. Ex. 5 at 19. At this visit, Petitioner complained to her primary care provider (“PCP”) only about cellulitis in her left hand – and did not mention any shoulder pain or related discomfort. Id. Then, on February 1, 2018 (now about four months after the vaccination – and two months after her last treater visit), Petitioner went back to her PCP complaining of a tender “knot” in her upper left arm that had been present for about a year (meaning before vaccination). Id. at 16-17. An ultrasound indicated no abnormalities. Id. at 42.

Over the next seven months through September 2018, Petitioner reported to medical providers for treatment of her unrelated migraines on six occasions. Ex. 2 at 11-15; Ex. 5 at 10-14. She never mentioned arm pain at any of these appointments, and sought no independent treatment for that admittedly-distinguishable condition.

Then, on January 7, 2019 (now well over a year after the vaccination date), Petitioner presented to Urgent Care and complained of 4/10 rated pain in her left arm after “getting [a] flu vaccine 3 years ago.” Ex. 2 at 3-4 (emphasis added). On exam, Petitioner displayed reduced range of motion (“ROM”) and was diagnosed with bursitis3 and adhesive capsulitis.4 Id. at 5. One week later, on January 16, 2019, Petitioner followed up with her PCP and reported “left arm pain and weakness for at least 2 years,” along with “electric” pain in her left bicep since her October 2017 vaccination. Ex. 5 at 8-9 (emphasis added).

An electromyography (“EMG”) test performed on April 24, 2019, showed cubital tunnel syndrome5 in both of Petitioner’s arms. Ex. 4 at 18-22. On May 29, 2019, Petitioner saw a neurologist and was diagnosed with cervical radiculopathy (pinched nerve). Id. at 4. She was referred to physical therapy and attended seven sessions. See generally Ex. 11.

On June 20, 2019, Petitioner’s orthopedist noted that her cubital tunnel syndrome did not explain her left shoulder issue. Ex. 6 at 10. MRIs and X-rays of Petitioner’s left shoulder revealed a large, calcific deposit in the supraspinatus tendon, tendinopathy, and bursitis. Id. at 11.

3 “Bursitis” is defined as “inflammation of a bursa [fluid-filled sac] occasionally accompanied by a calcific deposit in the underlying tendon.” Bursitis, Dorland’s Medical Dictionary Online, https://www.dorlandsonline.com/dorland/definition?id=7315&searchterm=bursitis (last visited Oct. 8, 2024). 4 “Adhesive capsulitis” is defined as “adhesive inflammation between the joint capsule and the peripheral articular cartilage of the shoulder with obliteration of the subdeltoid bursa, characterized by shoulder pain of gradual onset, with increasing pain, stiffness, and limitation of motion. Called also adhesive bursitis and frozen shoulder.” Adhesive capsulitis, Dorland’s Medical Dictionary Online, https://www.dorlandsonline.com/dorland/definition?id=62985&searchterm=adhesive+capsulitis (last visited Oct. 8, 2024).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Moberly v. Secretary of Health & Human Services
592 F.3d 1315 (Federal Circuit, 2010)
United States v. United States Gypsum Co.
333 U.S. 364 (Supreme Court, 1948)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Cedillo v. Secretary of Health & Human Services
617 F.3d 1328 (Federal Circuit, 2010)
Broekelschen v. Secretary of Health & Human Services
618 F.3d 1339 (Federal Circuit, 2010)
De Bazan v. Secretary of Health and Human Services
539 F.3d 1347 (Federal Circuit, 2008)
Althen v. Secretary of Health and Human Services
418 F.3d 1274 (Federal Circuit, 2005)
Rickett v. Secretary of Health & Human Services
468 F. App'x 952 (Federal Circuit, 2011)
Hibbard v. Secretary of Health & Human Services
698 F.3d 1355 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
McCoy v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mccoy-v-secretary-of-health-and-human-services-uscfc-2025.